Top 5 stocks of the day: Among the top Nifty losers are SBI, Axis Bank, ONGC, BPCL, and Bajaj Finance; winners include SBI Life Insurance, HDFC Life, Apollo Hospitals, Larsen & Toubro, and Tata Consumer Products. Sectors: PSU Bank index fell 2.5 percent, oil & gas index down 1.3 percent, and the auto, capital goods, FMCG, pharmaceutical, and real estate sectors all saw gains of 0.5 percent. The BSE Smallcap and Midcap indices had positive finishes.
Sensex and NSE Nifty50
The Nifty was down 33.40 points, or 0.17 percent, at 19,731.80, and the Sensex was down 187.75 points, or 0.28 percent, at 65,794.73 at the closing. A little over 1926 shares rose, 1654 shares fell, and 138 shares remained unchanged. In the tumultuous November 17 session, benchmark indices concluded lower, with the Nifty closing below 19,750.
Top 5 stocks of the day
|Name of companies||Change||Volume|
|SBI Life Insurance||3.95||31,92,944|
|Larsen & Toubro||1.81||13,25,050|
|Tata Consumer Products||1.52||9,61,365|
Lupin receives approval from the United States Food and Drug Administration
The United States Food and Drug Administration (USFDA) has approved Lupin’s Abbreviated New Drug Application for Ganirelix Acetate Injection, 250 mcg/0.5 mL Single-Dose Prefilled Syringe. This allows Lupin to market a generic version of Ganirelix Acetate Injection, 250 mcg/0.5 mL of Organon USA LLC, which is the reference listed drug (RLD). Lupin’s dedication to providing cutting-edge medical solutions is further demonstrated by Ganirelix, the company’s first injectable based on peptides. The product will be produced in India at Lupin’s Nagpur plant.
Disclaimer: (This information is provided solely for informational purposes. It is important to note that investing in the market or a business idea involves market risks. Before investing money as an investor/ owner/ partner, always consult an expert. DNP News Network Private Limited never advises to invest money on stocks or any specific business idea. We will not be liable for any financial losses.)